サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1528048

電気治療/ 生体電気医学の世界市場

Electroceuticals / Bioelectric Medicine

出版日
ページ情報
英文 277 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
電気治療/ 生体電気医学の世界市場
出版日: 2024年08月07日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 277 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

電気治療/ 生体電気医学の世界市場は2030年までに284億米ドルに達する見込み

2023年に185億米ドルと推定された電気治療/ 生体電気医学の世界市場は、分析期間2023-2030年にCAGR 6.3%で成長し、2030年には284億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである心臓ペースメーカー＆ICDは、CAGR 7.1％を記録し、分析期間終了までに179億米ドルに達すると予測されます。人工内耳分野の成長率は、分析期間中CAGR 5.3%と推定されます。

米国市場は77億米ドル、中国はCAGR7.2%で成長予測

米国の電気治療/ 生体電気医学市場は2023年に77億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに23億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは7.2%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ5.6%と6.1%と予測されています。欧州では、ドイツがCAGR約6.1％で成長すると予測されています。

世界の電気医療/生体電気医療市場- 主要動向と促進要因のまとめ

電気治療薬とは何か、そしてどのように医療を変革するのか？

電気製剤は、生体電気医薬品としても知られ、電気インパルスを使用して身体の神経系を調節し、さまざまな病気を治療することに焦点を当てた医学の最先端分野です。化学物質を用いて生物学的反応を引き起こす従来の医薬品とは異なり、電気治療薬は標的を絞った電気刺激を用いて神経活動を調節し、臓器機能に影響を与え、治療効果をもたらします。このアプローチは、ある種の慢性疼痛症候群、心不全、さらには精神疾患など、従来の医薬品に抵抗性を示す疾患や症状の治療に用いることができます。電気治療の原理は、脳とさまざまな器官をつなぐ神経の複雑なネットワークにあります。これらの神経信号を正確に調整することで、医師は生体電気の発生源から直接、異常を修正することを目指しています。

技術はどのように電気治療応用を進歩させているのか？

マイクロエレクトロニクスとバイオテクノロジーの進歩は、電気治療の分野を前進させる上で極めて重要です。神経マッピングの最新技術や、体内の標的部位に正確な電気インパルスを送ることができる小型の埋め込み型デバイスの開発により、この技術の応用可能性は大きく広がっています。これらのデバイスは、多くの場合、ウェアラブルまたは外部コントローラに接続され、患者固有のニーズに合わせて治療をリアルタイムで調整することができます。この精度の高さは、治療効果を高めるだけでなく、薬剤のような全身治療にありがちな副作用を最小限に抑えます。さらに、現在進行中の生体電気信号伝達と神経インターフェイスの研究により、さらに洗練された疾患治療法が開発されることが期待され、慢性疾患の管理に革命をもたらし、薬理学的介入への依存を減らす可能性があります。

現在の治療において、電気製剤はどのような役割を果たしているのか？

現在、電気製剤は様々な医療場面で応用されており、特に疼痛、神経障害、心臓疾患の管理に応用されています。例えば、脊髄刺激装置は、医薬品による治療が不十分あるいは不適切な患者の慢性疼痛を大幅に緩和することができます。同様に、脳深部刺激装置はパーキンソン病症状の治療に有望であり、罹患者の生活の質を大幅に改善します。心臓病学では、ペースメーカーや植え込み型除細動器（ICD）が異常な心臓のリズムを修正し、心不全や心臓突然死を予防します。このような多様な症状の治療における電気製剤の多用途性は、特に技術が向上し、神経系における新たな治療標的が発見されるにつれて、電気製剤が将来の医療現場における主力となる可能性を強調しています。

電気治療薬市場の成長を促すものは何か？

電気治療薬市場の成長は、技術革新、世界人口の高齢化、慢性疾患の負担増など、いくつかの要因によってもたらされます。生物医学の研究がより洗練され小型化された機器を提供するにつれ、電気製剤の適用範囲は拡大し、臨床医はより幅広い症状に、より高い有効性で対処できるようになります。世界の高齢者人口動態の変化により、心血管障害や神経疾患など、電気治療に適した慢性疾患の有病率が高まっています。さらに、ヘルスケアコストの上昇、特に医薬品の長期使用により、多くの場合、電気治療薬は費用対効果の高い代替品となっています。消費者の行動も変化しており、副作用が少なく薬物を摂取しない治療を好む傾向が強まっています。

調査対象企業の例（全50件）

  • Abbott Laboratories, Inc.
  • Medtronic PLC
  • Cochlear Ltd.
  • Aleva Neurotherapeutics SA
  • Biowave Corporation
  • MicroPort Scientific Corporation
  • BioElectronics Corporation
  • Beijing Pins Medical Co., Ltd.
  • Neuronetics, Inc.
  • Endonovo Therapeutics, Inc.
  • Axonics Modulation Technologies, Inc.
  • CEFALY-Technology
  • Nu Eyne Company Limited
  • Gimer Medical
  • Bioinduction

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP11726

Global Electroceuticals / Bioelectric Medicine Market to Reach US$28.4 Billion by 2030

The global market for Electroceuticals / Bioelectric Medicine estimated at US$18.5 Billion in the year 2023, is expected to reach US$28.4 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2023-2030. Cardiac Pacemakers & ICDs, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$17.9 Billion by the end of the analysis period. Growth in the Cochlear Implants segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.7 Billion While China is Forecast to Grow at 7.2% CAGR

The Electroceuticals / Bioelectric Medicine market in the U.S. is estimated at US$7.7 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.3 Billion by the year 2030 trailing a CAGR of 7.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.6% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.1% CAGR.

Global Electroceuticals/Bioelectric Medicine Market - Key Trends & Drivers Summarized

What Are Electroceuticals and How Are They Transforming Medicine?

Electroceuticals, also known as bioelectric medicines, represent a cutting-edge field in medical science that focuses on using electrical impulses to modulate the body's nervous system to treat a variety of ailments. Unlike traditional pharmaceuticals that use chemicals to provoke a biological response, electroceuticals employ targeted electrical stimulation to modulate nerve activity, influencing organ function and offering therapeutic benefits. This approach can be used to treat diseases and conditions that have been resistant to conventional medicines, such as certain chronic pain syndromes, heart failure, and even mental health disorders. The principle behind electroceuticals lies in the intricate network of nerves that link the brain to different organs; by precisely adjusting these nerve signals, doctors aim to correct abnormalities directly at their bioelectrical source.

How Is Technology Advancing Electroceutical Applications?

The advancements in microelectronics and biotechnology have been pivotal in propelling the field of electroceuticals forward. Modern techniques in neural mapping and the development of miniature, implantable devices capable of delivering precise electrical impulses to targeted areas within the body have significantly broadened the potential applications of this technology. These devices are often connected to wearable or external controllers that allow for real-time adjustments in therapy, tailored to patient-specific needs. This level of precision not only enhances the effectiveness of treatment but also minimizes side effects commonly associated with more systemic treatments like drugs. Additionally, ongoing research in bioelectrical signaling and neural interfaces promises to unlock even more sophisticated methods of treating diseases, potentially revolutionizing the management of chronic conditions and reducing dependence on pharmacological interventions.

What Role Does Electroceuticals Play in Current Medical Treatments?

Currently, electroceuticals are being applied in a variety of medical contexts, most notably in the management of pain, neurological disorders, and cardiac issues. For example, spinal cord stimulators can significantly alleviate chronic pain in patients for whom pharmaceutical treatments are insufficient or inappropriate. Similarly, deep brain stimulators have shown promise in treating Parkinson’s disease symptoms, substantially improving life quality for affected individuals. In cardiology, devices like pacemakers and implantable cardioverter-defibrillators (ICDs) correct abnormal heart rhythms, crucially preventing heart failure and sudden cardiac death. The versatility of electroceuticals in treating such diverse conditions underscores their potential to be a mainstay in future medical practices, particularly as technologies improve and new therapeutic targets within the nervous system are discovered.

What Drives the Growth in the Electroceuticals Market?

The growth in the electroceuticals market is driven by several factors, including technological innovations, an aging global population, and an increasing burden of chronic diseases. As biomedical research delivers more sophisticated and miniaturized devices, the applicability of electroceuticals expands, allowing clinicians to address a broader range of conditions with greater efficacy. The demographic shift towards an older population worldwide leads to a higher prevalence of chronic diseases, such as cardiovascular disorders and neurological conditions, which are well-suited for electroceutical interventions. Furthermore, the rising cost of healthcare, particularly the long-term use of pharmaceuticals, makes electroceuticals a cost-effective alternative in many cases. Consumer behavior is also shifting; there is a growing preference for treatments that have fewer side effects and do not involve drug intake, which often aligns well with electroceutical solutions.

Select Competitors (Total 50 Featured) -

  • Abbott Laboratories, Inc.
  • Medtronic PLC
  • Cochlear Ltd.
  • Aleva Neurotherapeutics SA
  • Biowave Corporation
  • MicroPort Scientific Corporation
  • BioElectronics Corporation
  • Beijing Pins Medical Co., Ltd.
  • Neuronetics, Inc.
  • Endonovo Therapeutics, Inc.
  • Axonics Modulation Technologies, Inc.
  • CEFALY-Technology
  • Nu Eyne Company Limited
  • Gimer Medical
  • Bioinduction

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Electroceuticals / Bioelectric Medicine - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • An Introduction to Electroceuticals/Bioelectric Medicine
    • Using Electrical Stimulation in Nerves: Historical Perspective
    • Types of Electroceutical Devices
    • Major Applications of Electroceuticals/Bioelectric Medicine
    • Global Market Prospects & Outlook
    • Implantable Electroceutical Devices: The Leading Category
    • Cardiac Pacemakers & Implantable Cardioverter Defibrillators Segment Lead the Global Market
    • Developed Regions Lead, Developing Economies to Spearhead Growth
    • Competition
    • Global DBS Market Share Breakdown of Revenues by Leading Players: 2020E
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Electroceutical/Biomedical Medicine Emerges to Overcome Drawbacks of Traditional Treatments
    • Faster Healing: A Key Benefit Fueling Growth in Electroceuticals Market
    • Ineffectiveness of Drug Therapy and Issues with Side Effects Present Opportunities for Electroceuticals Market
    • Disease-specific Electroceuticals to Drive Future Gains
    • Aging Global Population Raises Risk of Neurological & Cardiovascular Diseases, Fueling Market Outlook
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Growing Prevalence of Cardiovascular Diseases and Need for Effective Treatments Supports Market Growth
    • Global Annual Medical Cost of CVD in US$ Billion: 2010, 2015, 2020, 2025 and 2030
    • Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
    • Cardiac Pacemaker: A Solution for Cardiac Arrythmias
    • Transcatheter Cardiac Pacemakers: Benefits Fuel Market Growth
    • Technological Advancements to Transform Cardiac Pacemaker Devices Marketplace
    • Rising Incidence of Neurological Disorders and Need for Novel Therapies to Spur Market Growth
    • Annual Incidence of Adult-Onset Neurologic Disorders in the US
    • Bioelectronic Medicine Emerges as a Vital Therapy for Targeted Neuromodulation
    • Deep Brain Stimulators: Useful in Treatment of Neurodegenerative Diseases
    • Global Alzheimer's Prevalence by Age Group
    • Diagnosed Prevalence Cases of Parkinson's Disease in Select Countries
    • Select Available Deep Brain Stimulation Devices Available in the Market
    • Increasing Cases of Epilepsy Drives the Demand for Vagus Nerve Stimulation Devices
    • Developments in Vagal Nerve Stimulation (VNS) Devices
    • Spinal Cord Injuries Propel the Demand for Spinal Cord Stimulation Devices
    • TENS (Transcutaneous electrical nerve stimulation devices) Market Witnesses Rapid Growth
    • Biodegradable Devices For Nerve Recovery
    • Bioelectric Medicine: A Potential Treatment Approach for Crohn's Disease
    • Growing Prevalence of Hearing Loss Boosts Opportunities in the Cochlear Implants Market
    • Global Prevalence (%) by Severity of Hearing Loss
    • Vendors Focus on Innovations in Cochlear Implants
    • Developing Economies to Boost Long-term Prospects
    • Electroceutical Acupuncture: Emerging Pain Therapy
    • Neuropuncture - The Electroceutical Technology to Treat Pain & Injury
    • Bioelectronics Technology Fuels Advances in Next-Generation of Device Therapeutics
    • Market Benefits from the Significant Advantages of Bioelectronics
    • Overcoming the Challenges
    • Increasing Research Activity in Bioelectric Medicine Drives Market Opportunities
    • Market Poised to Benefit from the Development of New Bioelectronic Devices
    • Technological Advancements to Boost Growth Prospects
    • Rise in Healthcare Expenditure to Drive Growth
    • Elderly Healthcare Expenditure as a % of GDP in the US, Europe and Japan for 1970, 2010 and 2050
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Electroceuticals / Bioelectric Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Cardiac Pacemakers & ICDs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Cardiac Pacemakers & ICDs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Cardiac Pacemakers & ICDs by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Cochlear Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Cochlear Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Cochlear Implants by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Spinal Cord Stimulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Spinal Cord Stimulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Spinal Cord Stimulators by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Deep Brain Stimulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Deep Brain Stimulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Deep Brain Stimulators by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Hospitals, Clinics & ASCs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Hospitals, Clinics & ASCs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Hospitals, Clinics & ASCs by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Electroceuticals / Bioelectric Medicine Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Electroceuticals / Bioelectric Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Electroceuticals / Bioelectric Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Electroceuticals / Bioelectric Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Electroceuticals / Bioelectric Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Electroceuticals / Bioelectric Medicine by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Electroceuticals / Bioelectric Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Electroceuticals / Bioelectric Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Electroceuticals / Bioelectric Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Electroceuticals / Bioelectric Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of World 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION